ViaLase Inc.

ViaLase Inc. is a clinical-stage medical technology company developing innovative femtosecond laser solutions for glaucoma treatment. The company's proprietary ViaLuxe™ Laser System performs FLIGHT (Femtosecond Laser Image Guided High-Precision Trabeculotomy), a noninvasive procedure that creates apertures through the trabecular meshwork to manage mild to moderate primary open-angle glaucoma. Unlike traditional glaucoma interventions—which suffer from high noncompliance (topical medications), limited efficacy (selective laser trabeculoplasty), invasiveness (MIGS, filtration surgery)—ViaLase's approach combines non-incisional delivery with proprietary HD imaging for enhanced visualization and treatment validation. The technology eliminates vision-threatening complications associated with traditional surgery while allowing standalone execution. Led by CEO Shawn O'Neil and founder/CTO Tibor Juhasz, PhD, ViaLase has raised $40 million and is advancing regulatory clearance in the U.S. and European markets with significant commercial and clinical milestones ahead.